Scientist I (Gene Therapy/ Cell Cloning
Listed on 2026-08-22
-
Research/Development
Research Scientist, Medical Science -
Healthcare
Medical Science
Scientist I (Gene Therapy/ Cell Cloning)
San Diego, United States | Posted on 05/21/2026
Our client, a world leader in life sciences and biotechnology, is looking for a“Scientist I” based out of San Diego, CA.
Job Duration:
Long Term Contract(Possibility Of Extension)
Pay Rate : $46.43/hr onW2
Company Benefits:
Medical, Dental, Vision, Paid Sick leave, 401K
The Scientist I will be a vital contributor to our non-viral cell and gene therapy delivery platform, primarily focused on R&D for innovative nucleic acid payload technologies. This role involves evaluating novel mRNA and DNA designs using a range of molecular biology techniques, including plasmid cloning, in vitro validation, and the production of in vitro-transcribed mRNA. To verify successful expression, the scientist will utilize assays such as Western blot, qRT-PCR, and luciferase reporter assays.
Job Responsibilities- Design and clone expression vectors and IVT donor plasmids to support research initiatives.
- Execute DNA and mRNA transfections in mouse and human cell lines.
- Assess nucleic acid expression through molecular methods like qPCR, reporter assays and Western blotting.
- Maintenance of detailed electronic laboratory notebooks (ELN) and preparation of summary slides.
- Bachelor's degree with 5+ years or a Master's degree with 2+ years of experience in molecular biology, pharmaceutical sciences, or a related field.
- Molecular Biology:
Required proficiency in advanced cloning (Gibson assembly, Golden Gate, site-directed mutagenesis) and IVT. - Functional Assays:
Hands-on expertise in measuring transgene delivery success via reporter assays and qRT-PCR. - Cell Culture:
Preferred experience in genetic manipulation of cell lines and primary cells (e.g., T cells, monocytes, hepatocytes). - Desired proficiency in Snapgene, Prism, and MS Office.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).